Orion Capital Management’s Eli Lilly LLY Stock Holding History

Orion Capital Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.29M	Sell	1,401 -65	-4%	-$65.9K	0.44%	36
2025 Q4	$1.58M	Sell	1,466 -141	-9%	-$135K	0.53%	32
2025 Q3	$1.23M	Buy	1,607 +5	+0.3%	+$3.72K	0.43%	39
2025 Q2	$1.25M	Sell	1,602 -62	-4%	-$48.2K	0.48%	41
2025 Q1	$1.37M	Buy	1,664 +54	+3%	+$44.9K	0.58%	33
2024 Q4	$1.24M	Buy	1,610 +40	+3%	+$33.1K	0.55%	36
2024 Q3	$1.39M	Buy	1,570 +60	+4%	+$53.9K	0.67%	31
2024 Q2	$1.37M	Buy	1,510 +70	+5%	+$56K	0.72%	30
2024 Q1	$1.12M	Sell	1,440 -144	-9%	-$102K	0.6%	34
2023 Q4	$923K	Buy	1,584 +250	+19%	+$146K	0.54%	41
2023 Q3	$717K	Hold	1,334	–	–	0.47%	45
2023 Q2	$626K	Hold	1,334	–	–	0.41%	55
2023 Q1	$458K	Hold	1,334	–	–	0.31%	67
2022 Q4	$488K	Hold	1,334	–	–	0.36%	55
2022 Q3	$431K	Hold	1,334	–	–	0.35%	57
2022 Q2	$433K	Buy	1,334 +400	+43%	+$120K	0.34%	62
2022 Q1	$267K	Buy	934 +134	+17%	+$34.5K	0.16%	99
2021 Q4	$221K	Buy	+800	New	+$203K	0.13%	109

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $84.5B AUM 11.36% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Orion Capital Management's LLY Position: Q1 2026 in Review

Orion Capital Management reduced its Eli Lilly (LLY) stake by 4.4% in Q1 2026, selling an estimated $65.9K and leaving 1,401 shares worth $1.29M. The position accounts for 0.44% of the portfolio, ranked #36.

Orion Capital Management first reported a position in LLY in Q4 2021 and has held it in 18 quarters since. The position peaked at $1.58M in Q4 2025. 4,352 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

Orion Capital Management held 1,401 shares of Eli Lilly worth $1.29M as of Q1 2026.
Orion Capital Management sold 65 Eli Lilly shares in Q1 2026, an estimated $65.9K.
Eli Lilly made up 0.44% of Orion Capital Management's portfolio in Q1 2026, its #36 holding.
Orion Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 18 quarters since.
Orion Capital Management's Eli Lilly position peaked at $1.58M in Q4 2025.
4,352 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Orion Capital Management's 13F filing for Q1 2026, filed 14 May 2026.